alisol b has been researched along with chenodeoxycholic acid in 2 studies
| Studies (alisol b) | Trials (alisol b) | Recent Studies (post-2010) (alisol b) | Studies (chenodeoxycholic acid) | Trials (chenodeoxycholic acid) | Recent Studies (post-2010) (chenodeoxycholic acid) |
|---|---|---|---|---|---|
| 5 | 0 | 5 | 3,343 | 227 | 742 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, HR | 1 |
| Dong, PP; Feng, L; Huo, XK; Luan, ZL; Lv, X; Ma, XC; Ning, J; Sun, CP; Tian, XG; Wang, C; Zhang, BJ | 1 |
2 other study(ies) available for alisol b and chenodeoxycholic acid
| Article | Year |
|---|---|
Triterpenes from Alisma orientalis act as farnesoid X receptor agonists.
Topics: Alisma; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Triterpenes | 2012 |
Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism.
Topics: Alisma; Biological Products; Cells, Cultured; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Molecular Docking Simulation; Molecular Structure; Mutagenesis, Site-Directed; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Terpenes | 2019 |